Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 4,692,000 | 4,329,000 | 5,205,795 | 4,508,000 | 4,493,000 |
| Cost of Goods | 1,054,000 | 1,153,000 | 1,265,327 | 1,014,000 | 1,073,000 |
| Gross Profit | 3,638,000 | 3,176,000 | 3,940,468 | 3,494,000 | 3,420,000 |
| Operating Expenses | 2,185,000 | 1,871,000 | 2,379,578 | 1,898,000 | 1,998,000 |
| Operating Income | 1,453,000 | 1,305,000 | 1,560,890 | 1,596,000 | 1,422,000 |
| Interest Expense | 79,000 | 72,000 | N/A | 10,000 | 0 |
| Other Income | -6,000 | 6,000 | 152,027 | 18,000 | -20,000 |
| Pre-tax Income | 1,368,000 | 1,239,000 | 1,712,917 | 1,604,000 | 1,402,000 |
| Income Tax | 300,000 | 271,000 | 173,275 | 19,000 | 135,000 |
| Net Income Continuous | 1,068,000 | 968,000 | 1,539,642 | 1,585,000 | 1,267,000 |
| Net Income | $1,068,000 | $968,000 | $1,539,642 | $1,585,000 | $1,267,000 |
| EPS Basic Total Ops | 0.07 | 0.06 | 0.10 | 0.11 | 0.08 |
| EPS Basic Continuous Ops | 0.07 | 0.06 | 0.10 | N/A | N/A |
| EPS Diluted Total Ops | 0.07 | 0.06 | 0.10 | 0.11 | 0.08 |
| EPS Diluted Continuous Ops | 0.07 | 0.06 | 0.10 | N/A | N/A |
| EBITDA(a) | $1,683,000 | $1,538,000 | $1,881,750 | $1,840,805 | $1,697,094 |